Epithelial membrane protein 2 (EMP2) binding reagents and their therapeutic uses in ocular diseases

Details for Australian Patent Application No. 2011217785 (hide)

Owner United States Government Department of Veterans Affairs The Regents of the University of California

Inventors Gordon, Lynn K.; Braun, Jonathan; Morales, Shawn; Telander, David G.; Wadehra, Madhuri

Agent Allens Patent & Trade Mark Attorneys

Pub. Number AU-A-2011217785

PCT Pub. Number WO2011/103599

Priority 61/306,073 19.02.10 US

Filing date 22 February 2011

Wipo publication date 25 August 2011

International Classifications

A61K 39/395 Medicinal preparations containing antigens or antibodies - Antibodies

A61K 31/7105 - Natural ribonucleic acids, i.e. containing only riboses attached to adenine, guanine, cytosine or uracil and having 3'-5' phosphodiester links

A61K 38/16 Medicinal preparations containing peptides - Peptides having more than 20 amino acids

A61P 27/00 Drugs for disorders of the senses

A61P 27/02 Drugs for disorders of the senses

Event Publications

13 September 2012 PCT application entered the National Phase

  PCT publication WO2011/103599 Priority application(s): WO2011/103599

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011217794-Method for activation and conjugation of biomolecules

2011217784-Platelet-derived growth factor compositions and methods for the treatment of tendinopathies